Prognostic Impact of Genetic Polymorphism in Mineralocorticoid Receptor and Comorbidity With Hypertension in Androgen-Deprivation Therapy

Mineralocorticoid receptor (MR) signaling which is closely associated with hypertension plays important roles in resistance to antiandrogen therapy in prostate cancer. However, its impact on the prognosis in androgen-deprivation therapy (ADT) has not been elucidated. Then, we investigated the impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiota, Masaki, Fujimoto, Naohiro, Imada, Kenjiro, Kashiwagi, Eiji, Takeuchi, Ario, Inokuchi, Junichi, Tatsugami, Katsunori, Kajioka, Shunichi, Uchiumi, Takeshi, Eto, Masatoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305359/
https://www.ncbi.nlm.nih.gov/pubmed/30619769
http://dx.doi.org/10.3389/fonc.2018.00635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305359/
https://www.ncbi.nlm.nih.gov/pubmed/30619769
http://dx.doi.org/10.3389/fonc.2018.00635

Ejemplares similares